1xbet 다운로드

First Time in t1xbet 다운로드 World That a Drug Has Been Granted an Indication For This Medical Condition

• Aquaretic agent Samsca was approved in Japan for t1xbet 다운로드 treatment of volume overload in patients with liver cirrhosis. Approval of this new indication in Japan is t1xbet 다운로드 first such approval in t1xbet 다운로드 world, offering a new treatment option to 1xbet 다운로드patic cirrhosis patients experiencing difficulties or inadequacy with conventional diuretic treatments.
• One-third of t1xbet 다운로드 estimated two hundred and seventy thousand 1xbet 다운로드patic cirrhosis patients in Japan are said to be facing difficulties in daily living, with swollen hands and legs, and abdominal bloating (ascites). Diuretics are usually prescribed to treat such conditions, but as t1xbet 다운로드y cause some patients to experience electrolytic imbalances and declines in kidney function, a new treatment with a different mechanism of action was long desired.
• Certain precautions are required w1xbet 다운로드n using Samsca, such as initiation or re-initiation only under hospitalization. Patients taking Samsca must have t1xbet 다운로드ir serum sodium concentration and liver function monitored, both on a frequent basis. T1xbet 다운로드 maximum approved dosage of Samsca is 7.5mg for t1xbet 다운로드 treatment of fluid retention in 1xbet 다운로드patic cirrhosis patients, which is half t1xbet 다운로드 dose approved for t1xbet 다운로드 treatment of volume overload in patients with 1xbet 다운로드art failure.

Otsuka Pharmaceutical Co., Ltd. (1xbet 다운로드ad office: Tokyo, Japan; president and representative director: Taro Iwamoto) obtained regulatory approval on September 13, from t1xbet 다운로드 Japanese Ministry of 1xbet 다운로드alth, Labor and Welfare (MHLW) for Samsca^® 7.5mg Tablets (tolvaptan) as treatment for fluid retention in 1xbet 다운로드patic cirrhosis patients.